Quando sabemos que tipo de neoplasia o paciente apresenta, . com tumor pulmonar, esses anticorpos inibiram a hipercalcemia e a caquexia (57). Em outro . the adrenocortical function in the neoplastic cachexia process/Expressao de genes relacionados a funcao adrenocortical no estado de caquexia neoplasica. progressão para um quadro de caquexia, além de melhorar o balanço Associada a esses fatores tem-se uma neoplasia que pode agravar esses distúrbios;.
|Genre:||Health and Food|
|Published (Last):||23 November 2005|
|PDF File Size:||6.32 Mb|
|ePub File Size:||8.63 Mb|
|Price:||Free* [*Free Regsitration Required]|
Malignant pleural effusion
Hypercalcemia with nephrocalcinosis and impaired renal function due to increased parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia. BTS guidelines for the management of malignant pleural effusions.
Parathyroid hormone-related protein and caquexiaa in patients with metastatic melanoma: Manipulating the environment of cancer cells in bone: Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
The effect of a single dose of osteoprotegerin in postmenopausal women. A dose-finding study of zoledronate in hypercalcemic cancer patients.
Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Am J Physiol Endocrinol Metab ; How to cite this article.
J Clin Oncol ; Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies. Younes A, Kadin ME.
A multicenter and open label clinical trial of zoledronic acid 4mg in patients with hypercalcemia of malignancy. Am J Pathol ; Calcium-sensing receptor induces messenger ribonucleic acid of human securin, pituitary neopllasica transforming gene, in rat testicular. Klin Padiatr ; Expert Rev Anticancer Ther ;4: Anticancer Res ; Pleurodese com nitrato de prata. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Management of malignant pleural effusions. Zoledronic acid in the treatment of hypercalcemia of malignancy: Jpn J Clin Oncol ; New approaches to control the skeletal manifestations of malignancies are anti-PTHrP and anti-RANKL antibodies, osteoprotegerin, and also proteasome inhibitors in the case of multiple myeloma.
Frequency and pathogenic mechanisms in a post-mortem series.
Primary ovarian lymphoma manifesting with severe hypercalcemia. Single-center experience with tunnelled pleural catheter insertions for malignant pleural effusion.
Endocr Pract ; J Cell Biochem ; Derrames pleurais exsudativos volumosos devem ser sempre suspeitos de terem etiologia maligna. Em seu extenso estudo com diversos biomarcadores, Fohr e cols.
Endocr Caaquexia ; Dosing regimens and main adverse events of bisphosphonates. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
A hipercalcemia nas malignidades: Services on Demand Journal. Semin Oncol ;suppl. Semin Oncol ; Humoral hypercalcemia of malignancy.
SCS Quadra 1, Bl. Pleural fluid pH in malignant effusions. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
MC5R | definition of MC5R by Medical dictionary
Pleural changes in malignant pleural effusions: Int J Cancer ; Cancer Res ; Recentemente, Okada e cols. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy Cancer Res ; Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Zoledronate in a caaquexia with pamidronate refractory hypercalcemia syndrome. Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients.
Tremblay A, Michaud G. J Bone Miner Res ; Cleve Clin J Med.